参考文献
1. https://www.google.com.hk/imgres?imgurl=https://live.staticflickr.com/65535/49628500797_9bd72858d7_b.jpg&imgrefurl=https://www.flickr.com/photos/governortomwolf/49628500797&tbnid=mbseedo7yqhh-m&vet=12ahukewin34dsnbjrahunezqkht6ed74qmygseguiarclaq..i&docid=d62phde0i-unem&w=1024&h=683&q=covid-19 &hl=zh-cn&ved=2ahukewin34dsnbjrahunezqkht6ed74qmygseguiarclaq
2. to kkw., et al. covid-19 re-infection by a phylogenetically distinct sars-coronavirus-2 strain confirmed by whole genome sequencing. clinical infectious diseases, ciaa1275, https://doi.org/10.1093/cid/ciaa1275.
3. liu f., et al. positive sars-cov-2 rna recurs repeatedly in a case recovered from covid-19: dynamic results from 108 days of follow-up. pathog dis. 2020 jun 1;78(4):ftaa031.
4. yuan b., et al. recurrence of positive sars-cov-2 viral rna in recovered covid-19 patients during medical isolation observation. sci rep. 2020; 10: 11887.
5. duggan nm., et al. interpreting dynamic sars-cov-2 test results through a case report. am j emerg med. 2020; 10.1016/j.ajem.2020.06.079.
6. zheng s., et al. viral load dynamics and disease severity in patients infected with sars-cov-2 in zhejiang province, china, january-march 2020: retrospective cohort study. bmj. 2020 apr 21;369:m1443.
7. hao s., et al. decreased b cells on admission associated with prolonged viral rna shedding from the respiratory tract in coronavirus disease 2019: a case-control study.
j infect dis. 2020 jul 6;222(3):367-371.
8. https://www.sciencemag.org/news/2020/08/some-people-can-get-pandemic-virus-twice-study-suggests-no-reason-panic
9. https://m.weibo.cn/7454177482/4541710014882021
10. https://m.weibo.cn/7454177482/4542069291614281
11. su ycf., et al. discovery and genomic characterization of a 382-nucleotide deletion in orf7b and orf8 during the early evolution of sars-cov-2. mbio. 2020 jul 21;11(4):e01610-20.
12. young be., et al. effects of a major deletion in the sars-cov-2 genome on the severity of infection and the inflammatory response: an observational cohort study. lancet. 2020 aug 18:s0140-6736(20)31757-8.
13. rodda lb., et al. functional sars-cov-2-specific immune memory persists after mild covid-19. medrxiv. 2020.8.11.20171843.
14. mentesh av., et al. sars-cov-2 specific memory b cells frequency in recovered patient remains stable while antibodies decay over time. medrxiv. 2020.08.23.20179796.
15. https://www.nytimes.com/2020/08/24/health/coronavirus-reinfection.html#click=https://t.co/aszpjgg8wu16. https://mp.weixin.qq.com/s/nsfcea86zuzjjnrejd_qjg17. walsh ee., et al. rna-based covid-19 vaccine bnt162b2 selected for a pivotal efficacy study. medrxiv. 2020.8.17.20176651.18. xia s., et al. effect of an inactivated vaccine against sars-cov-2 on safety and immunogenicity outcomes: interim analysis of 2 randomized clinical trials. jama. 2020 aug 13:e2015543.19. keech c., et al. first-in-human trial of a sars cov 2 recombinant spike protein nanoparticle vaccine. medrxiv. 2020.08.05.20168435.20. corbett ks., et al. sars-cov-2 mrna vaccine design enabled by prototype pathogen preparedness. nature. 2020 aug 5.21. patel a., et al. intradermal-delivered dna vaccine provides anamnestic protection in a rhesus macaque sars-cov-2 challenge model. biorxiv. 2020.07.28.225649.22. chandrashekar a., et al. sars-cov-2 infection protects against rechallenge in rhesus macaques. science. 2020 aug 14;369(6505):812-817.23. mercado nb., et al. single-shot ad26 vaccine protects against sars-cov-2 in rhesus macaques. nature. 2020 jul 30. doi: 10.1038/s41586-020-2607-z.
